---
schema_version: "secwatch.filing_event.v1"
accession: "0001420800-22-000016"
form_type: "8-K"
ticker: "ENOV"
cik: "0001420800"
company_name: "Enovis CORP"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:54:02.584066+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Enovis Q2 revenue $395M (+11%), adjusted EPS $0.59 (+44%), full-year guidance updated

## Summary
- Reported EPS from continuing ops $2.21; adjusted EPS $0.59 vs $0.41 YoY, includes ~$0.10 one-time tax benefit.
- Organic growth 3% (5% per-day); adjusted EBITDA $56M, +11% YoY, with $2M currency pressure.
- Completed acquisitions of Insight Medical Systems (ARVIS AR surgical guidance) and 360 Med Care (Australian distributor).
- Updated FY2022 outlook: organic growth 6-9% reaffirmed; adjusted EBITDA $235-255M; adjusted EPS $2.15-$2.35.
- Currency headwinds expected to impact full-year; Q2 tax planning benefit lifted adjusted EPS.

## SEC filing metadata
- accession: 0001420800-22-000016
- form_type: 8-K
- ticker: ENOV
- cik: 0001420800
- company_name: Enovis CORP
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420800/000142080022000016/0001420800-22-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420800/000142080022000016/cfx-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420800-22-000016
- JSON: https://secwatch.observer/filing/0001420800-22-000016.json
- Plain text: https://secwatch.observer/filing/0001420800-22-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.